Secretory Carcinoma of Male Breast: Case Report and Review of the Literature

Secretory carcinoma is a rare low-grade breast carcinoma, initially termed “juvenile breast cancer,” but it is now known to occur in adults of both sexes. It is the only epithelial tumor of the breast with a balanced translocation, t(12;15), that creates an ETV6-NTRK3 gene translocation. In this pap...

Full description

Bibliographic Details
Main Authors: S. Gabal, S. Talaat
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.4061/2011/704657
id doaj-d7946e0cd2704a5a9eebf4612fd9658d
record_format Article
spelling doaj-d7946e0cd2704a5a9eebf4612fd9658d2020-11-25T00:28:42ZengHindawi LimitedInternational Journal of Breast Cancer2090-31892011-01-01201110.4061/2011/704657704657Secretory Carcinoma of Male Breast: Case Report and Review of the LiteratureS. Gabal0S. Talaat1Department of Pathology, Faculty of Medicine, Cairo University, Giza 12655, EgyptDepartment of Pathology, Faculty of Medicine, Cairo University, Giza 12655, EgyptSecretory carcinoma is a rare low-grade breast carcinoma, initially termed “juvenile breast cancer,” but it is now known to occur in adults of both sexes. It is the only epithelial tumor of the breast with a balanced translocation, t(12;15), that creates an ETV6-NTRK3 gene translocation. In this paper, a 19-year-old male patient has had a right breast mass for 9 years which suddenly increased in size with no evidence of palpable axillary lymph nodes. The mass was excised for frozen section and was diagnosed as malignant growth for simple mastectomy. Microscopic examination revealed the classical features of secretory carcinoma. The tumor cells were positive for EMA and S-100 protein and focally positive for cytokeratin and ER but negative for progesterone receptor, CD34, and CEA. Four months later the patient developed ipsilateral axillary lymph node enlargement, with lymph node metastases in five of the dissected 19 lymph nodes. The patient was treated with six courses of chemotherapy and radiotherapy. Conclusion. Though considered an indolent neoplasm, secretory carcinoma does metastasize to lymph nodes. Surgery in the form of mastectomy with axillary clearance is the treatment of choice. This paper includes a rare case report of secretory carcinoma in young male patient, with axillary lymph node metastasis in spite of the indolent nature that this tumor is known to display.http://dx.doi.org/10.4061/2011/704657
collection DOAJ
language English
format Article
sources DOAJ
author S. Gabal
S. Talaat
spellingShingle S. Gabal
S. Talaat
Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
International Journal of Breast Cancer
author_facet S. Gabal
S. Talaat
author_sort S. Gabal
title Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
title_short Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
title_full Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
title_fullStr Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
title_full_unstemmed Secretory Carcinoma of Male Breast: Case Report and Review of the Literature
title_sort secretory carcinoma of male breast: case report and review of the literature
publisher Hindawi Limited
series International Journal of Breast Cancer
issn 2090-3189
publishDate 2011-01-01
description Secretory carcinoma is a rare low-grade breast carcinoma, initially termed “juvenile breast cancer,” but it is now known to occur in adults of both sexes. It is the only epithelial tumor of the breast with a balanced translocation, t(12;15), that creates an ETV6-NTRK3 gene translocation. In this paper, a 19-year-old male patient has had a right breast mass for 9 years which suddenly increased in size with no evidence of palpable axillary lymph nodes. The mass was excised for frozen section and was diagnosed as malignant growth for simple mastectomy. Microscopic examination revealed the classical features of secretory carcinoma. The tumor cells were positive for EMA and S-100 protein and focally positive for cytokeratin and ER but negative for progesterone receptor, CD34, and CEA. Four months later the patient developed ipsilateral axillary lymph node enlargement, with lymph node metastases in five of the dissected 19 lymph nodes. The patient was treated with six courses of chemotherapy and radiotherapy. Conclusion. Though considered an indolent neoplasm, secretory carcinoma does metastasize to lymph nodes. Surgery in the form of mastectomy with axillary clearance is the treatment of choice. This paper includes a rare case report of secretory carcinoma in young male patient, with axillary lymph node metastasis in spite of the indolent nature that this tumor is known to display.
url http://dx.doi.org/10.4061/2011/704657
work_keys_str_mv AT sgabal secretorycarcinomaofmalebreastcasereportandreviewoftheliterature
AT stalaat secretorycarcinomaofmalebreastcasereportandreviewoftheliterature
_version_ 1725334809285230592